Investigating how certain proteins affect blood flow blockages in sickle cell disease
Oxidative Cysteine Modification by Thiol Isomerases in Sickle Cell Disease
This study is looking at how certain proteins might cause painful blockages in blood vessels for people with sickle cell disease, with the hope of finding new ways to help reduce these painful episodes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Bloodworks NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11127027 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of thiol isomerases, a type of protein, in causing vaso-occlusive events in sickle cell disease (SCD). These events are painful blockages in blood vessels that can occur despite existing treatments. The study aims to explore how oxidative stress and specific proteins contribute to these blockages, potentially leading to new treatment strategies. By examining the interactions of these proteins in the body, the research seeks to identify ways to reduce the frequency and severity of vaso-occlusive crises in patients with SCD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with sickle cell disease who experience recurrent vaso-occlusive crises.
Not a fit: Patients without a diagnosis of sickle cell disease or those who do not experience vaso-occlusive events may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly reduce painful vaso-occlusive events in patients with sickle cell disease.
How similar studies have performed: Previous research has shown promise in targeting oxidative stress and related proteins in sickle cell disease, indicating that this approach may lead to meaningful advancements.
Where this research is happening
Seattle, United States
- Bloodworks — Seattle, United States (Active)
Researchers
- Principal investigator: Yang, Moua — Bloodworks
- Study coordinator: Yang, Moua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.